Patents
COMPOSITIONS FOR TRANSFECTING RESISTANT CELL TYPES Pending in US as US2019292566 AA and granted in the UK, France and Germany as EP3519578 B2. NONVIRAL MODIFICATION OF T CELL GENE EXPRESSION Pending and published in Canada as CA3133394 AA, Australia as AU2020260280 AA, South Korea as KR20210133982 A, CN113710811 A, pending and unpublished in the United States NUCLEIC ACID-CONTAINING LIPID PARTICLES AND RELATED METHODS Patented in Russian Federation as RU 2573409 C2, in Japan as JP 5823405 B2 and JP 6234971 B2, in China as CN 102712935 B; granted in United States as patent nos. 9,758,795 & 10,041,091, and pending as US 2019032087 AA, and Pending and published in Canada as CA 2816925. |
LIMIT SIZE LIPID NANOPARTICLES AND RELATED METHODS
Granted in US as US 9,943,846 and 10,843,194 in Canada as CA 2853316, pending and published in the US as US 2021023556 AA; Europe as EP 3915545 A1, and in Japan as JP 2020121986..
LOW COMPLEXITY FLOW CONTROL IN A MICROFLUIDIC MIXER
Granted in Canada as CA 3044713 B, Pending in the US as US2020139321 A1; in China as CN110214047 A; and in Europe as EP3570967.
NUCLEIC ACID-CONTAINING LIPID PARTICLES AND RELATED METHODS
Patented in Russian Federation as RU 2573409 C2, in Japan as JP 5823405 B2 and JP 6234971 B2, in China as CN 102712935 B; granted in United States as patent nos. 9,758,795 & 10,041,091, and pending as US 2019032087 AA, and Pending and published in Canada as CA 2816925.
SMART MICROFLUIDIC MIXING INSTRUMENT AND CARTRIDGES
Granted in Canada as CA3027643 C, the US as US11059039; Pending and published in the US as US 2020023358 AA, Australia as AU 2017292906, Canada as 3096121, Europe as EP 3481539 A1; Japan as JP2019528174 T2; China as CN 109414664 A; and S.Korea as KR20190025836 A.BIFURCATING MIXERS AND METHODS OF THEIR USE AND MANUFACTURE Granted in the United States as US 10,076,730; 10,688,456; US 10835878 BB; in the UK, France, Germany, Italy, Belgium, Switzerland, Sweden, and The Netherlands as EP 3400097 B1, in Canada as CA3009691 B; Pending in China as CN 108778477 A; ; in Australia as 2016385135; in Japan as JP2018-535128; and in South Korea as 10-2018-7022607.
|
DEVICE FOR FORMULATING PARTICLES AT SMALL VOLUMES
Granted in US as 10159652, in China as CN 105813721 B; and in Japan as JP6640079 B2; and in Canada as CA 2927358 B. Pending and published in Europe as EP 3057693 A1.
LABORATORY MIXER (design)
Granted in Europe as EM007568894-0001, Canada as 190416, and in the US as D919110.
CONTINUOUS FLOW MICROFLUIDIC SYSTEM
Granted in Japan as JP 6764870 B2; Pending and published in the United States as US as US 2021023514 and US 20210113974; in Canada as CA 2977768; in Europe as EP 3262424; and in South Korea as KR 20170126944 .
Disposable microfluidic cartridge (utility)
Granted in the United States as US 10597291 BB, in Canada as CA 2983804 B; and in China as No. CN 107921381
Pending in Japan as JP2018525209 T2.
MICROFLUIDIC CHIP (legacy Spark design)
Granted in the United States as US D800335
MICROFLUIDIC CHIP (Spark™ chip design)
Granted in US as D849265, Europe as EC004417335-0001, in China as CN3044727713 S, in Japan as JP1601624 S.Disposable microfluidic cartridge (utility)
Granted in the United States as US 10597291 BB, in Canada as CA 2983804 B; and in China as No. CN 107921381
Pending in Japan as JP2018525209 T2.
MICROFLUIDIC CARTRIDGE (Ignite design)
Granted in the United States as D878622 and granted in Europe as EM005746518-0001
MICROFLUIDIC CARTRIDGE for (Ignite design)
Pending in the US. Granted in Europe as EM007451612-0001, granted on January 30, 2020
Disposable microfluidic cartridge (utility)
Granted in the United States as US 10597291 BB, in Canada as CA 2983804 B; and in China as No. CN 107921381
Pending in Japan as JP2018525209 T2.
MICROFLUIDIC CARTRIDGE (Blaze design)
Granted in the United States as D812242
MICROFLUIDIC CARTRIDGE (Blaze design)
Granted in the United States as D800336
COMPOSITIONS FOR TRANSFECTING RESISTANT CELL TYPES
Pending in US as US2019292566 AA and granted in the UK, France and Germany as EP3519578 B2.
NONVIRAL MODIFICATION OF T CELL GENE EXPRESSION
Pending and published in Canada as CA3133394 AA, Australia as AU2020260280 AA, South Korea as KR20210133982 A, CN113710811 A, pending and unpublished in the United States
NUCLEIC ACID-CONTAINING LIPID PARTICLES AND RELATED METHODS
Patented in Russian Federation as RU 2573409 C2, in Japan as JP 5823405 B2 and JP 6234971 B2, in China as CN 102712935 B; granted in United States as patent nos. 9,758,795 & 10,041,091, and pending as US 2019032087 AA, and Pending and published in Canada as CA 2816925.LIPID NANOPARTICLES FOR TRANSFECTION AND RELATED METHODS
Granted in the United States as US 10,342,760, in Japan as JP6605446 B2, in France and the UK as EP 297013B1, in Germany as DE201460069189T Pending and published in Canada as CA 2906732;; in China as CN 105143456 A., and in the US as US 2019307689.
|
LIMIT SIZE LIPID NANOPARTICLES AND RELATED METHODS
Granted in US as US 9,943,846 and 10,843,194 in Canada as CA 2853316, pending and published in the US as US 2021023556 AA; Europe as EP 3915545 A1, and in Japan as JP 2020121986..
LOW COMPLEXITY FLOW CONTROL IN A MICROFLUIDIC MIXER
Granted in Canada as CA 3044713 B, Pending in the US as US2020139321 A1; in China as CN110214047 A; and in Europe as EP3570967.
NUCLEIC ACID-CONTAINING LIPID PARTICLES AND RELATED METHODS
Patented in Russian Federation as RU 2573409 C2, in Japan as JP 5823405 B2 and JP 6234971 B2, in China as CN 102712935 B; granted in United States as patent nos. 9,758,795 & 10,041,091, and pending as US 2019032087 AA, and Pending and published in Canada as CA 2816925.
SMART MICROFLUIDIC MIXING INSTRUMENT AND CARTRIDGES
Granted in Canada as CA3027643 C, the US as US11059039; Pending and published in the US as US 2020023358 AA, Australia as AU 2017292906, Canada as 3096121, Europe as EP 3481539 A1; Japan as JP2019528174 T2; China as CN 109414664 A; and S.Korea as KR20190025836 A.BIFURCATING MIXERS AND METHODS OF THEIR USE AND MANUFACTURE Granted in the United States as US 10,076,730; 10,688,456; US 10835878 BB; in the UK, France, Germany, Italy, Belgium, Switzerland, Sweden, and The Netherlands as EP 3400097 B1, in Canada as CA3009691 B; Pending in China as CN 108778477 A; ; in Australia as 2016385135; in Japan as JP2018-535128; and in South Korea as 10-2018-7022607.
|
DEVICE FOR FORMULATING PARTICLES AT SMALL VOLUMES
Granted in US as 10159652, in China as CN 105813721 B; and in Japan as JP6640079 B2; and in Canada as CA 2927358 B. Pending and published in Europe as EP 3057693 A1.
LABORATORY MIXER (design)
Granted in Europe as EM007568894-0001, Canada as 190416, and in the US as D919110.
CONTINUOUS FLOW MICROFLUIDIC SYSTEM
Granted in Japan as JP 6764870 B2; Pending and published in the United States as US as US 2021023514 and US 20210113974; in Canada as CA 2977768; in Europe as EP 3262424; and in South Korea as KR 20170126944 .
Disposable microfluidic cartridge (utility)
Granted in the United States as US 10597291 BB, in Canada as CA 2983804 B; and in China as No. CN 107921381
Pending in Japan as JP2018525209 T2.
MICROFLUIDIC CHIP (legacy Spark design)
Granted in the United States as US D800335
MICROFLUIDIC CHIP (Spark™ chip design)
Granted in US as D849265, Europe as EC004417335-0001, in China as CN3044727713 S, in Japan as JP1601624 S.
Disposable microfluidic cartridge (utility)
Granted in the United States as US 10597291 BB, in Canada as CA 2983804 B; and in China as No. CN 107921381
Pending in Japan as JP2018525209 T2.
MICROFLUIDIC CARTRIDGE (Ignite design)
Granted in the United States as D878622 and granted in Europe as EM005746518-0001
MICROFLUIDIC CARTRIDGE for (Ignite design)
Pending in the US. Granted in Europe as EM007451612-0001, granted on January 30, 2020
Disposable microfluidic cartridge (utility)
Granted in the United States as US 10597291 BB, in Canada as CA 2983804 B; and in China as No. CN 107921381
Pending in Japan as JP2018525209 T2.
MICROFLUIDIC CARTRIDGE (Blaze design)
Granted in the United States as D812242
MICROFLUIDIC CARTRIDGE (Blaze design)
Granted in the United States as D800336
COMPOSITIONS FOR TRANSFECTING RESISTANT CELL TYPES
Pending in US as US2019292566 AA and granted in the UK, France and Germany as EP3519578 B2.
NONVIRAL MODIFICATION OF T CELL GENE EXPRESSION
Pending and published in Canada as CA3133394 AA, Australia as AU2020260280 AA, South Korea as KR20210133982 A, CN113710811 A, pending and unpublished in the United States
NUCLEIC ACID-CONTAINING LIPID PARTICLES AND RELATED METHODS
Patented in Russian Federation as RU 2573409 C2, in Japan as JP 5823405 B2 and JP 6234971 B2, in China as CN 102712935 B; granted in United States as patent nos. 9,758,795 & 10,041,091, and pending as US 2019032087 AA, and Pending and published in Canada as CA 2816925.LIPID NANOPARTICLES FOR TRANSFECTION AND RELATED METHODS
Granted in the United States as US 10,342,760, in Japan as JP6605446 B2, in France and the UK as EP 297013B1, in Germany as DE201460069189T Pending and published in Canada as CA 2906732;; in China as CN 105143456 A., and in the US as US 2019307689.